BlastomaBrain Webinar

24 March 2021 | 16:00 – 17:00
with Neurix COO Sébastien Mosser and
InnoSer oncology study director Kim Frederix


A platform for glioblastoma drug development

blastomabrain minibrain organoids

In vivo like in vitro environment

Derived from patient human cells, BlastomaBrain makes a 3D drug screening platform for glioblastoma tumors, providing results that cannot readily be replicated in 2D cultures.

neurix sebastien mosser


The webinar is centered around a scientific presentation by Sébastien Mosser, COO of our partner company Neurix, which is is a spin-off from the University of Geneva.

Drug development

InnoSer offers BlastomaBrain platform as a service for glioblastoma drug development. With our scientific expertise and state-of-the-art facilities, we provide you fast and reliable results.


Your place at this webinar is just a few clicks away!

Please use the sign up form here to register for the webinar. You can scroll down within the embedded window and easily fill out the form. Overall, we expect to spend approximately 45min on introducing the platform to you as well as discussing its applications.

Cannot attend the webinar? You can still register and receive the recording afterwards.

We will reserve time for your questions but you can always feel free to direct your questions to our business development managers via their contact info below.

We look forward to welcoming you to our event!

Let’s connect:

Having trouble with Captcha?

  • Visit registration page in a new window.
  • Reach out via the contact form below to register manually. We are happy to help!
  • Sign in and use the Zoom App or Web SDK to avoid any issues.

Talk to InnoSer’s BDMs

Pascal Simoens profile

Pascal Simoëns (Global)

(+32) 460957428

Edith Simar profile

Edith Simar (French speaking)

(+32) 472809002